US Bancorp
BMY.RT

US Bancorp’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

US Bancorp’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-436,421
Closed -$300K – 4040
2020
Q4 		$300K Sell
436,421
-32,751
-7% -$69.8K ﹤0.01% 1693
2020
Q3 		$1.05M Sell
469,172
-46,410
-9% -$133K ﹤0.01% 972
2020
Q2 		$1.84M Sell
515,582
-46,829
-8% -$169K ﹤0.01% 746
2020
Q1 		$2.14M Sell
562,411
-48,620
-8% -$160K 0.01% 649
2019
Q4 		$1.84M Buy
+611,031
New +$1.59M ﹤0.01% 806

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

US Bancorp's BMY.RT Position: Q1 2021 in Review

US Bancorp sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 436,421 shares — an estimated $300K sold.

US Bancorp first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $2.14M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • US Bancorp reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • US Bancorp sold 436,421 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $300K.
  • US Bancorp first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • US Bancorp's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $2.14M in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on US Bancorp's 13F filing for Q1 2021, filed 28 Apr 2021.